RFK Jr. on ibogaine: promising signal, exaggerated certainty
Kennedy has praised ibogaine's potential for PTSD and depression; the science is promising in places but far from definitive.
The Statement
the most promising treatment for depression and PTSD
Source: Scientific American coverage of Senate hearing (Senate hearing coverage).
Context
Kennedy's comments came amid federal attention to psychedelic research and ibogaine access. The policy debate is moving faster than the clinical evidence base.
What The Evidence Shows
Ibogaine has signals in addiction research and emerging interest for trauma-related conditions, but evidence for depression and PTSD remains limited and safety monitoring is central.
Where It Lands
Ibogaine is a serious research candidate.
There is enough signal to justify controlled research, especially around addiction and trauma-related outcomes.
Ibogaine is already proven as the top treatment for PTSD and depression.
Evidence is not yet strong enough for that ranking or certainty.
Bottom Line
Ibogaine deserves serious study. Calling it the most promising treatment anyone has seen is stronger than the published evidence supports.
Editorial commentary. Not medical or legal advice. Not endorsed by or affiliated with Robert F. Kennedy Jr..